Safety and Efficacy of Tirofiban in Acute Ischemic Stroke Patients Receiving Endovascular Treatment: A Meta-Analysis | Zendy

Zhiyong Fu | Zendy; Chuanli Xu | Zendy; Xin Liu | Zendy; Zhengze Wang | Zendy; Lianbo Gao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Safety and Efficacy of Tirofiban in Acute Ischemic Stroke Patients Receiving Endovascular Treatment: A Meta-Analysis

Author(s) -

Zhiyong Fu,

Chuanli Xu,

Xin Liu,

Zhengze Wang,

Lianbo Gao

Publication year - 2020

Publication title -

cerebrovascular diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.221

H-Index - 104

eISSN - 1421-9786

pISSN - 1015-9770

DOI - 10.1159/000509054

Subject(s) - tirofiban , medicine , odds ratio , confidence interval , meta analysis , subgroup analysis , stroke (engine) , myocardial infarction , mechanical engineering , percutaneous coronary intervention , engineering

Tirofiban is widely used in clinical practice for acute ischemic stroke (AIS). However, whether tirofiban increases the bleeding risk or improves the outcome of AIS patients with endovascular treatment (ET) is unknown. The aim of this meta-analysis is to evaluate the safety and efficacy of tirofiban compared with those without tirofiban in AIS patients receiving ET.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research